Dx Deals: QuidelOrtho Acquires LEX Diagnostics, Plans to Switch Out Respiratory Testing Platforms
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2
Already a member? Log in here
Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge
The pandemic may have set the stage for a jump in infections from these four nemeses
Already a member? Log in here
Assessing At-Home Testing Accuracy
Patients desire direct-to-consumer testing, but are the results this testing provides accurate and reliable?
Already a member? Log in here
ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Already a member? Log in here
A Lasting Impact: COVID-19 and Cancer Screening
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
Already a member? Log in here